Serum antibodies to HTLV-I in human demyelinating disease
- 1 April 1987
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 75 (4) , 231-233
- https://doi.org/10.1111/j.1600-0404.1987.tb07925.x
Abstract
Serum HTLV-I antibodies were measured in 17 MS patients and 2 closely matched control groups by 2 different independent assays. A highly sensitive particle agglutination test was used to detect HTLV-I core protein antigens and an immunoblot assay with Escherichia coli-expressed P21E transmembrane protein was employed to detect antibodies to HTLV-I evelope antigens. No serologic evidence of prior HTLV-I infection in our population of multiple sclerosis (MS) or Guillain-Barre Syndrome (GBS) patients was found.Keywords
This publication has 7 references indexed in Scilit:
- Human retroviral env and gag polypeptides: serologic assays to measure infection.The Journal of Immunology, 1986
- Multiple sclerosis and human T-cell lymphotropic retrovirusesNature, 1985
- High-level bacterial expression and purification of human T-lymphotropic virus type I (HTLV-I) transmembrane env proteinGene Analysis Techniques, 1985
- The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndromeBlood, 1985
- Diagnostic Potential for Human Malignancies of Bacterially Produced HTLV-I Envelope ProteinScience, 1984
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979